is there a shortage of glp 1 drugs National Hispanic Medical Association | After compounded GLP-1 were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and GLP-1 Agonists Weight Loss Drugs
Description
Methods A retrospective study was conducted using electronic medical records from 2014 to 2019 for adults with T2D at the Valencia Clnico-Malvarrosa Department of Health (Valencia, Spain)

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.

Safe, medical weight loss support with proven results

The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%
